n. a *biological therapy that inhibits *interleukin 1, an inflammatory *cytokine involved in the pathogenesis of rheumatoid arthritis. It reduces long-term cartilage and joint damage and is self-administered subcutaneously on a daily basis. Risk of infection and allergy, including mild injection-site reactions, may occur and last several weeks.